App-Quantinova.ai

The use of totally implantable central venous access ports for the treatment of multidrug-resistant tuberculosis (MDR-TB) at the programmatic level. Prospective cohort study

Aliaksandr Skrahin - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

IGG4-related disease causing sudden cardiac death

Richard Haigh - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Prednisolone

Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism in gastrointestinal and pancreatobiliary cancer

Jang ho Lee - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

rivaroxaban

The evaluation of medication adherence in patients with pulmonary thromboembolism

Ilknur Basyigit - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Thrombotic disorders (blood coagulation test and Padua Prediction Score for risk of lung thrombosis)in hospitalized patients with community-acquired pneumonia (CAP)

Mariia Krykhtina - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The prognostic value of Red cell distribution width(RDW) in acute pulmonary thromboembolism

Samaneh Parsa - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

Non-Contrast Chest CT Scans In Detection Of Pulmonary Thromboembolism

Lamia Shaaban - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Factors affecting recurrence and bleeding complications in patients withvenous thromboembolism

Yasemin Ates - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical characteristics and outcome of patients with Behçet’s Disease and thrombosis

Serhat Erol - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Cyclophosphamide

Variants of genes related to cardiovascular disease in patients with pulmonary thromboembolism

Ayse Gul Zamani - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Non-invasive assessment of pulmonary microcirculation at rest and exercise in patients with previous pulmonary thromboembolism

Danilo Cortozi Berton - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Nitric oxide

Incidence and risk factors for venous thrombosis after venovenous extracorporeal membrane oxygenation in adult patients with acute respiratory failure

Christoph Fisser - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Hughes-Stovin syndrome, a rare cause of thrombosis and pulmonary artery aneurysm: a case report

Selma Yalin - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Cyclophosphamide

Anti-Inflammatory Activities of Sulfated Non-Anticoagulant Heparin Derivative Beyond Its Anti-Sickling and Anti-Selectin for the Effective Management of Sickle Cell Disease

Noureldien Darwish - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

Reconstruction of Sickle Cell Disease with Circulating Sickling Red Blood Cells in Novel Humanized Cytokines and Liver Mistrg Mice

Yuanbin Song - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Predictors of Maternal Morbidity Among Participants Enrolled in the Sickle Cell Disease Implementation Consortium Registry

Rita V Masese - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Hydroxyurea

Immunophenotypes and Clinical Outcomes in Adult Patients with Sickle Cell Disease: Lymphopenia Correlates with End Organ Damage

Stephen Zachary Peeke - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Nanoparticle-Directed Targeting of Clustered PSGL-1 Mitigates Neutrophil-Derived Thrombosis in Antiphospholipid Antibody Syndrome

David R Sweet - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Integrin αIIbβ3 Regulates Platelet-Procoagulant Activity in the Lung

Tomasz Brzoska - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

eptifibatide

Characterization of Thromboembolic Events Occurring during the Avatrombopag Immune Thrombocytopenia (ITP) Clinical Development Program

Caroline I. Piatek - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Avatrombopag

Filters

7277 Abstracts